Nikolaos Xydias, general manager at GSK Bulgaria, explains the commitment of GSK to cutting-edge medicines and vaccines targeting respiratory diseases and HIV and highlights the reasons why pharmaceutical multinationals should put Bulgaria on their business map.
This is your first time as a country manager. How did you prepare yourself for this position?
"We are currently in the process of moving from our older genericised portfolio to our newer assets which we have launched during the last four years."
